Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

By Martin R TramŁr, D. Carroll, F. Campbell, John M Reynolds, A. Moore, Henry McQuay, R. Moore. British medical journal, 2001

616 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Genomic and Chemical Diversity in Cannabis (2015, background): “101 High delta-9-tetrahydrocannabinolic acid (THCA) (23) content has been selected for in 102 many strains due to its potential to be converted to delta-9-tetrahydrocannabinol (THC), which has 103 potent psychoactive (24), appetite-stimulating (25), analgesic (26) and antiemetic (27) effects.”
Consensus Guidelines for Managing Postoperative Nausea and Vomiting (2003, neutral): “trol of chemotherapy-induced sickness (64), have not”
Cannabis and the brain. (2003, background): “Smoking remains the most ef®cient means of delivering the drug and experienced users can titrate the dose by adjusting the frequency and depth of inhalation (Iversen, 2000).”
Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (2014, background): “218,219 Two meta-analyses have addressed the impact of intraoperative supplemental oxygen on the incidence of PONV.”
The Endocannabinoid System as an Emerging Target of Pharmacotherapy (2006, background): “However, they were also more toxic, with dizziness, dysphoria, hallucinations, and paranoia being the most prominent undesirable side effects (Tramér et al., 2001).”